文献速递甲状腺疾病

MarginView3D:将新型三维手术病理报告拓展用于侵袭性pT4甲状腺癌及其他肿瘤手术

MarginView3D: Extending Novel 3D Surgical Pathology Reporting for Use in Invasive pT4 Thyroid Cancer and Other Surgical Oncologic Procedures.
PubMed 文献 · Thyroid · 2026-03-09

该研究介绍了一种新型术中工作流程与软件平台MarginView3D(MV3D),整合三维扫描与标准化「暂停」以提升冰冻切片分析精度和手术病理报告质量。在5例侵袭性pT4甲状腺癌(4例气管切除、1例胸骨肿块切除)中应用,生成整合三维扫描、标注影像和视听摘要的动态报告,并展示实时沟通指导补充切缘实现R0切除的案例。

要点

  • MV3D整合三维扫描与标准化暂停,用于术中切缘评估与病理记录。
  • 在5例侵袭性pT4甲状腺癌中应用,包括4例气管切除和1例胸骨肿块切除。
  • 案例5显示MV3D促进外科与病理实时双向沟通,指导补充切缘实现R0切除。

核心结论

  • MV3D是一种用于晚期甲状腺癌术中切缘评估与记录的新型可扩展方法,可能影响未来外科肿瘤实践。

研究设计与样本

  • 描述性研究,介绍MV3D手术病理报告软件及整合三维扫描和标准化暂停的手术工作流程。
  • 在5例侵袭性pT4甲状腺癌病例中应用该方法。

主要发现

  • MV3D用于指导4例气管切除和1例胸骨肿块切除的术中切缘评估、沟通和病理记录。
  • 每例生成整合三维扫描、标注影像和视听摘要的动态手术病理报告,供多学科使用。
  • 案例5中MV3D促进外科医生与病理医生实时双向沟通,指导精确获取补充切缘,实现R0切除。

关键数值与推荐

  • 美国甲状腺协会最新临床实践指南将切缘状态列为估计复发风险的关键因素。
  • 侵袭性pT4甲状腺癌的成功切除需要使用冰冻切片分析。
  • 目前没有标准化的术中手术切缘评估方法。

临床怎么用

  • 在侵袭性pT4甲状腺癌术中,可采用MV3D整合三维扫描与标准化暂停进行切缘评估和病理记录。
  • MV3D可促进外科与病理实时沟通,指导补充切缘的精确获取。
  • 生成的动态报告整合三维扫描、标注影像和视听摘要,便于多学科使用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The American Thyroid Association's most recent clinical practice guidelines include margin status as a key factor to estimate risk of recurrence. Unlike most thyroid cancers, the successful resection of invasive pT4 thyroid cancers necessitates the use of frozen section analysis (FSA). There is no standardized method for intraoperative surgical margin assessment. We developed a novel intraoperative workflow and software platform, MarginView3DTM (MV3D), to enhance the precision of FSA and improve surgical pathology reporting in head and neck cancer. Here, we demonstrate its use in invasive thyroid cancer. METHODS: We describe the MV3DTM surgical pathology reporting software and detail our surgical workflow, which incorporates 3D scanning technology and standardized "timeouts" to facilitate intraoperative communication and pathologic documentation. This approach was utilized in five invasive pT4 thyroid cancer cases. RESULTS: MV3DTM was used to guide intraoperative margin assessment, communication, and pathologic documentation in four tracheal resections and one sternal mass resection. A final surgical pathology report was generated for each case, integrating 3D scans, annotated radiographs, and audiovisual summaries into a dynamic interface for multidisciplinary use. We highlight case 5, where MV3DTM facilitated bidirectional communication between the surgeon and pathologist to guide precise harvesting of supplemental margins. The surgeon and pathologist collaborated in real time to address at-risk areas requiring immediate re-resection. An R0 resection was achieved, and all relevant details were captured within MV3DTM. CONCLUSIONS: We have utilized our novel approach extensively in head and neck cancer. Here, we highlight it as a tool for the management of invasive pT4 thyroid cancer. As a brief summary of new and innovative research, this study introduces MV3DTM as a novel and scalable approach to intraoperative margin assessment and documentation in advanced thyroid cancer, with the potential to inform future practice in surgical oncology.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Comess SR, Kapustin JE, Nurimba M, et al. MarginView3D: Extending Novel 3D Surgical Pathology Reporting for Use in Invasive pT4 Thyroid Cancer and Other Surgical Oncologic Procedures. Thyroid. 2026. PMID: 41801365. doi:10.1177/10507256261431842

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。